AASM News Archive


Positions, Statements & Definitions News RSS Feed

Items per page
select
 
 
 
1
Page 1 of 1, items 1 to 5 of 5
AASM response to closing of Sleep HealthCenters facilities in New England and Arizona
 
January 27, 2013
The American Academy of Sleep Medicine encourages patients who have been affected by the closing of multiple Sleep HealthCenters facilities in New England and Arizona to contact a local AASM accredited sleep disorders center to make arrangements for the immediate transition of their medical care. An online directory of AASM accredited member centers is available at www.sleepeducation.com, or patients can contact the AASM national office at 630-737-9700 or inquiries@aasmnet.org to get contact information for a local sleep center accredited by the AASM.
AASM statement on new FDA safety announcement for sleeping pills
 
January 10, 2013
The AASM advises all physicians to prescribe sleep medications according to the new dose requirements and offers important safety tips for patients.
AASM statement: CDC data on drowsy driving highlights need to treat sleep illness
 
January 03, 2013
Drivers should seek treatment for suspected sleep apnea to reduce risk of drowsy driving
American Academy of Sleep Medicine Statement on the Use of Provigil
 
July 19, 2012
Provigil, which comprises the drug modafinil, is a stimulant that originally received FDA approval in 1998. A variation of the medication, marketed as Nuvigil and composed of armodafinil, was approved by the FDA in 2007.
Statement in response to Jan. 16 NPR/Kaiser Health report
 
January 27, 2012
The American Academy of Sleep Medicine, which represents more than 10,000 sleep medicine physicians and professionals, would like to clarify some erroneous statements reported by Kaiser and NPR in its story

Copyright © 2012 American Academy of Sleep Medicine
2510 North Frontage Road, Darien, IL 60561 Telephone: (630) 737-9700 Fax: (630) 737-9790